Browse by People

Collapse authors list.
Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao ORCID: 0000-0002-5489-6450, Reynolds, Helen ORCID: 0000-0001-7443-4520, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan et al (show 18 more authors) , Byrne, Kelly, Seden, Kay, Twimukye, Adelline, Theunissen, Helene, Hodel, Eva Maria ORCID: 0000-0001-5821-1685, Chiong, Justin ORCID: 0000-0001-8063-6399, Hu, Nai-Chung, Burger, David, Wang, Duolao, Byamugisha, Josaphat, Alhassan, Yussif, Bokako, Sharon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Taegtmeyer, Miriam, Orrell, Catherine, Lamorde, Mohammed, Myer, Landon and Khoo, Saye ORCID: 0000-0002-2769-0967 (2022) 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. LANCET HIV, 9 (8). E534-E543.

Collapse authors list.
Clark, Richard E ORCID: 0000-0002-1261-3299, Polydoros, Fotios, Apperley, Jane F, Milojkovic, Dragana, Rothwell, Katherine, Pocock, Christopher, Byrne, Jennifer, de lavallade, Hugues, Osborne, Wendy, Robinson, Lisa et al (show 4 more authors) , O'Brien, Stephen G, Read, Lucy, Foroni, Letizia and Copland, Mhairi (2019) De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial. The Lancet Haematology, 6 (7). E375-E383.